Application of metabonomics in breast cancer / 药学实践杂志
Journal of Pharmaceutical Practice
; (6): 139-145, 2023.
Article
de Zh
| WPRIM
| ID: wpr-965562
Bibliothèque responsable:
WPRO
ABSTRACT
Breast cancer is a kind of malignant tumor discovered lately, with a high incidence and a poor prognosis. The shortage of relevant biological biomarkers lead to the unsatisfactory treatment efficacy and the early diagnosis in breast cancer. Metabolomics is a new discipline that uses high-throughput analysis techniques to study the dynamic changes of endogenous metabolites under the influence of different pathological physiological stimulation or gene mutations, which has provided a novel way for biomarker screening and disease diagnosis and treatment. The overview of metabolomics and its applications in breast cancer early diagnosis, drug efficacy evaluation, and disease prognosis were summarized in this review.
Texte intégral:
1
Base de données:
WPRIM
Langue:
Zh
Journal:
Journal of Pharmaceutical Practice
Année:
2023
Type de document:
Article